<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02740855</url>
  </required_header>
  <id_info>
    <org_study_id>Endtidal ethanol</org_study_id>
    <nct_id>NCT02740855</nct_id>
  </id_info>
  <brief_title>Endtidal Ethanol in Sclerotherapy</brief_title>
  <official_title>Endtidal Ethanol in Sclerotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <brief_summary>
    <textblock>
      During the ethanol sclerotherapy procedure, the investigators will record doses of and time
      of ethanol injections and record ethanol concentrations in endtidal breath every 5 minutes.
      Furthermore after every ethanol injection the concentration will be measured every minute for
      5 minutes. To do so, the investigators will attach a breath alcohol testing device to the
      expiratory carbon dioxide measuring unit. Since this is the new standard of the university
      hospital Berne all patients undergo the same procedure. There is no study specific
      intervention. In this study the investigators will only document the breath alcohol levels,
      doses and timing of ethanol injections. All other data will be obtained from the anesthesia
      information system. During the two months of the study, the investigators will also record
      endtidal ethanol concentration after anesthesia in the postoperative care unit discharge from
      the unit.

      The intention is to show the correlation between injected ethanol doses and measured endtidal
      ethanol concentration over the entire time of the intervention.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Actual">October 2018</completion_date>
  <primary_completion_date type="Actual">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Endtidal ethanol concentrations in mg/dl over time</measure>
    <time_frame>1 year 2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bloodpressure in mmHg over time</measure>
    <time_frame>1 year 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bloodpressure in mmHg over injected peripheral ethanol volume</measure>
    <time_frame>1 year 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse rate in beats er minute over time</measure>
    <time_frame>1 year 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse rate in beats er minute over injected peripheral ethanol volume</measure>
    <time_frame>1 year 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endtidal ethanol concentrations in mg/dl over injected ethanol volume</measure>
    <time_frame>1 year 2 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">70</enrollment>
  <condition>Ethanol Concentration</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alcomed 3011Â®</intervention_name>
    <description>Endtidal ethanol measurement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing ethanol sclerotherapy at the university hospital Berne over the age
        of 18.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing ethanol sclerotherapy at the university hospital Berne

        Exclusion Criteria:

          -  under the age of 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bern University Hospital and University of Bern</name>
      <address>
        <city>Bern</city>
        <zip>3011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>April 5, 2016</study_first_submitted>
  <study_first_submitted_qc>April 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2016</study_first_posted>
  <last_update_submitted>November 8, 2018</last_update_submitted>
  <last_update_submitted_qc>November 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sclerotherapy</keyword>
  <keyword>ethanol</keyword>
  <keyword>pulmonal hypertension</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

